A case of nephrotic syndrome associated with renovascular hypertension successfully treated with candesartan

Hypertension Research

Volumn 26, Issue 1, 2003, Pages 123-127

  Takahashi, Fumihiko ^a   Hasebe, Naoyuki ^a   Chinda, Junko ^a   Okada, Motoi ^a   Takeuchi, Toshiharu ^a   Hirayama, Tomoya ^a   Imamoto, Chiiko ^b   Kikuchi, Kenjiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

Candesartan; Proteinuria; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; RENIN; SPIRONOLACTONE;

AGED; ARTERIOGRAPHY; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG METABOLISM; FATIGUE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOKALEMIA; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; LEG MUSCLE; MALE; MUSCLE WEAKNESS; NEPHROTIC SYNDROME; PATIENT REFERRAL; PHYSICAL EXAMINATION; PLASMA RENIN ACTIVITY; PROTEINURIA; RENOVASCULAR HYPERTENSION; TREATMENT OUTCOME;

EID: 0037276259     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.123     Document Type: Article

References (17)

1. Berlyne GM, Tavill AS, deeBaker SB: Renal artery stenosis and the nephrotic syndrome. Q J Med 1964; 33: 325-335.
2. Takekoshi Y, Matsuda I, Itakura K: A case of renovascular hypertension with the nephrotic syndrome. Jpn Circ J 1971; 35: 937-940.
3. Montoliu J, Botey A, Torras A, Darnell A, Revert L: Renin-induced massive proteinuria in man. Clin Nephrol 1979; 11: 267-271.
4. Fujii S, Kasahara H, Oguchi H: A case of renovascular hypertension with nephrotic syndrome accompanied by focal segmental glomerulosclerosis-like lesion in the contralateral kidney. Nippon Jinzo Gakkai Shi 1991; 33: 1017-1024 (in Japanese).
5. Bhowmik D, Dash SC, Jain D, Agarwal SK, Tiwari SC, Dinda AK: Renal artery stenosis and focal segmental glomerulosclerosis in the contralateral kidney. Nephrol Dial Transplant 1998; 13: 1562-1564.
6. Ogata H, Ishiyama N, Hamabe K, et al: Renovascular hypertension with massive proteinuria. Intern Med 1996; 35: 569-573.
7. Ben-Chitrit S, Korzets Z, Podjarny E, Bernheim J: Reversal of nephrotic syndrome due to renovascular hypertension by successful percutaneous angioplasty and stenting. Nephrol Dial Transplant 1995; 10: 1460-1461.
8. Fujioka S, Sasakawa O, Suzuki R, et al: A case of renovascular hypertension with the nephrotic syndrome. Jpn J Med 1986; 25: 317-320.
9. Martinez Vea A, Garcia Ruiz C, Carrera M, Oliver JA, Richart C: Effect of captopril in nephrotic-range proteinuria due to renovascular hypertension. Nephron 1987; 45: 162-163.
10. Navar LG, Harrison-Bernard LM: Intrarenal angiotensin II augmentation in angiotensin II dependent hypertension. Hypertens Res 2000; 23: 291-301.
11. Brenner BM, Bohrer MP, Baylis CH, Deen WM: Determinants of glomerular permselectivity: insights derived from observation in vivo. Kidney Int 1977; 12: 229-237.
12. Halimi JM, Ribstein J, Cailar GD, Mimran A: Nephrotic-range proteinuria in patients with renovascular disease. Am J Med 2000; 108: 120-126.
13. Russo D, Pisani A, Balletta MM, et al: Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 1999; 33: 851-856.
14. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with nephropathy due to type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
15. Lewis EJ, Hunsicker LG, Clarke WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
16. Ogawa Y, Haneda T, Hirayama T, et al: Effects with lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension. Hypertens Res 2000; 23: 607-612.
17. Shigihara T, Sato A, Hayashi K, et al: Effects of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes. Hypertens Res 2000; 23: 219-226.